D.E. Shaw & Co
ALBO

D.E. Shaw & Co’s Albireo Pharma Inc ALBO Stock Holding History

D.E. Shaw & Co’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-17,237
Closed -$438K – 4372
2019
Q4 		$438K Buy
+17,237
New +$345K ﹤0.01% 3459
2019
Q3 		– Sell
-7,240
Closed -$233K – 4080
2019
Q2 		$233K Buy
+7,240
New +$242K ﹤0.01% 3408
2014
Q4 		– Sell
-357
Closed -$18K – 4324
2014
Q3 		$18K Sell
357
-473
-57% -$27.2K ﹤0.01% 4046
2014
Q2 		$54K Sell
830
-541
-39% -$37.6K ﹤0.01% 4106
2014
Q1 		$112K Buy
1,371
+628
+85% +$57.2K ﹤0.01% 4165
2013
Q4 		$51K Buy
+743
New +$54.4K ﹤0.01% 4396

Other funds holding ALBO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

D.E. Shaw & Co's ALBO Position: Q1 2020 in Review

D.E. Shaw & Co sold out of Albireo Pharma Inc (ALBO) in Q1 2020, closing a stake of 17,237 shares — an estimated $438K sold.

D.E. Shaw & Co first reported a position in ALBO in Q4 2013 and held it in 6 quarters. The position peaked at $438K in Q4 2019. 69 funds tracked by Wall St. Rank hold ALBO as of Q1 2020.

  • D.E. Shaw & Co reported no remaining Albireo Pharma Inc position as of Q1 2020 after selling out during the quarter.
  • D.E. Shaw & Co sold 17,237 Albireo Pharma Inc shares in Q1 2020, an estimated $438K.
  • D.E. Shaw & Co first reported a position in Albireo Pharma Inc in Q4 2013 and held it in 6 quarters.
  • D.E. Shaw & Co's Albireo Pharma Inc position peaked at $438K in Q4 2019.
  • 69 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2020.

Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.